Home › Conditions › Neutropenic Sepsis
Oncology
Neutropenic Sepsis
Neutropenic sepsis is a medical emergency in patients with neutrophils <1.0 × 10⁹/L (severe <0.5) with fever ≥38°C or clinical suspicion of sepsis. Antibiotics must be given within 60 minutes of recognition. Mortality is 2–21% — delays are fatal. SACT (chemotherapy) history is the key clue.
UKONS Neutropenic Sepsis Pathway
The pathway
Recognise
Any patient on systemic anti-cancer treatment (SACT) with fever ≥38°C or feeling unwell. Neutropenia confirmed by FBC. Fever may be absent in profound neutropenia — any deterioration counts.
Sepsis 6 adapted
- O₂ if needed
- Blood cultures (peripheral x2 + from each lumen of central line)
- IV antibiotics ASAP
- FBC urgently — if neutrophils <1.0, treat as neutropenic sepsis regardless of source
Broad-spectrum antibiotics within 60 min
- Piperacillin-tazobactam (Tazocin) 4.5 g IV Q6h with normal renal function; adjust to renal function/local policy
- Or meropenem 1 g IV Q8h if Tazocin-resistant organisms likely
- Do NOT add a glycopeptide just because there is a central line (NICE CG151) — only for a patient-specific or local microbiological indication
- Do NOT remove the line as part of initial empiric management
Identify source & risk stratify
- MASCC score ≥21 = low risk
- Blood cultures
- CXR
- urine dip
- line inspection
- dental screen
- CT chest/abdomen if source unclear or high-risk
GCSF (Granulocyte colony-stimulating factor)
Filgrastim SC prescribed by oncology team. Consider in life-threatening neutropenic sepsis or prolonged neutropenia. Do NOT use as routine first-line — requires oncology input.
Antimicrobial review at 48–72h
- Review cultures and clinical response; narrow antibiotics if appropriate
- Fever at 72–96 h: urgent oncology/haematology + microbiology review, with fungal investigations
- High-risk prolonged neutropenia: consider caspofungin
- Fluconazole does not cover Aspergillus
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Piperacillin-tazobactam | 4.5 g Q6h with normal renal function | IV | First-line in neutropenic sepsis. Give within 60 minutes; adjust dose/interval for renal function and local antimicrobial policy. |
| Meropenem | 1g Q8h | IV | Broad-spectrum. Use if ESBL/resistant organisms suspected. |
| Vancomycin | 1g Q12h (levels-guided) | IV | Not empirically for a central line alone (CG151 1.4.3.3). Add only on a patient-specific or local microbiological indication. Levels 48h after starting. |
| Caspofungin | 70 mg loading dose, then 50 mg once daily; if >80 kg, 70 mg once daily | IV | Specialist-led; high-risk persistent neutropenic fever. |
When to escalate
- Haemodynamic instability — ITU, vasopressors (noradrenaline)
- MASCC score <21 (high-risk) — inpatient admission mandatory
- Still febrile at 72h despite antibiotics — consider fungal, resistant organisms, ITU
- Suspected typhlitis (RIF pain, diarrhoea) — CT abdomen + surgical review
Reference: UKONS Neutropenic Sepsis Guidelines 2023 / NICE CG151
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.